PubMed HealthSearch

PubMed · 2390312

Developments in the new genetics.

Abstract

The advent of recombinant DNA has introduced novel ways of diagnosing genetic disorders. The application of these techniques in affected families, coupled with genetic counselling, should help prevent the recurrence of a proportion of cases, and thereby reduce a considerable amount of suffering, and in some cases the expense of caring for a severely affected individual. However, such aims may be achieved only when the importance of such services is more widely recognized and they become more generally available. Counselling and prenatal diagnostic services have been available in University Centres of Medical Genetics for at least the last 20 years yet still only a proportion of the population at risk avail themselves of these services. The role of Health Departments in ensuring that those at risk are aware of and then use these facilities is clear. Health education must play an important role in this regard. Furthermore, there is a real need for financial support to employ adequately trained medical and technical staff in such centres. Currently, these problems are being debated by such bodies as the Clinical Genetics Society and the Royal College of Physicians. With the co-operation, help and support of Public Health Departments in the future, these exciting developments will not remain within the confines of research laboratories but will be extended to the community at large. In this way all those at risk in the population can benefit.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A E Emery. 1990. Developments in the new genetics.. https://doi.org/10.1093/oxfordjournals.pubmed.a042508

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Theoretical possibility of using gene therapy in malignant diseases].

The rapidly growing knowledge in molecular biology opened new methodological approaches, pharmacological targets, such as gene transfer or application of antisense oligomers. It is necessary to be familiar with the benefits and drawbacks of gene therapy to avoid the traps of unrealistic expectations and hopes, to solve moral and practical problems of gene manipulations and to find its proper values and rationals in the management of malignant tumors.

DNA, Recombinant

Constitutive expression of the beta-phaseolin gene in different tissues of transgenic alfalfa does not ensure phaseolin accumulation in non-seed tissue.

Phaseolin is a glycoprotein that constitutes the major storage protein in bean seeds. The phaseolin gene promoters function in a seed-specific manner. In an attempt to understand if events following transcription of the gene also contribute to the seed-specific accumulation of the phaseolin protein, we studied the effect of substituting the constitutive CaMV-35S promoter for the beta-phaseolin gene promoter on expression of the phaseolin gene in different plant organs. A chimeric gene consisting of the 35S promoter, the coding sequence of the beta-phaseolin gene (all five introns and six exons) and the 3'-flanking region of the beta-phaseolin gene, was introduced into alfalfa via Agrobacterium tumefaciens. While all organs examined shared high levels of phaseolin transcripts, the only organ that showed significant accumulation of the phaseolin protein were the mature seeds. Co-migration of the major immunoreactive polypeptides from the non-seed organs with the authentic beta-phaseolin polypeptides on SDS-PAGE indicates that the protein in non-seed organs undergoes correct post-translational processing and modification, but are more unstable in a non-seed environment.

DNA, Recombinant